Skip to main content
ImageneBio, Inc. logo

ImageneBio, Inc. — Investor Relations & Filings

Ticker · IMA ISIN · US45175G1085 US Manufacturing
Filings indexed 286 across all filing types
Latest filing 2022-04-27 Regulatory Filings
Country US United States of America
Listing US IMA

About ImageneBio, Inc.

https://inmagenebio.com/

ImageneBio, Inc. is a clinical-stage biotechnology company that develops therapeutics for patients with immunological, autoimmune, and inflammatory diseases. The company's lead candidate is IMG-007, a next-generation investigational anti-OX40 monoclonal antibody. IMG-007 is designed with an extended half-life to target and inhibit OX40 receptor signaling without depleting T cells, aiming to provide a potential best-in-class treatment with enhanced efficacy, safety, and patient convenience.

Recent filings

Filing Released Lang Actions
DEFA14A
Regulatory Filings
2022-04-27 English
DEF 14A
Proxy Solicitation & Information Statement
2022-04-27 English
FORM 4 SUBMISSION
Director's Dealing
2022-04-26 English
FORM 3 SUBMISSION
Director's Dealing
2022-04-26 English
FORM 8-K
Regulatory Filings
2022-04-13 English
FORM 8-K
Regulatory Filings
2022-04-06 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.